Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2026-01-06 @ 9:18 AM
Study NCT ID:
NCT02971761
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2016-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-21
First Submit QC Date:
None
Study First Post Date:
2016-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-10-07
Results First Submit QC Date:
None
Results First Post Date:
2022-06-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-14
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL